NCT04686760View on ClinicalTrials.gov

Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

December 15, 2021

Study Completion Date

March 15, 2022

Conditions
Corona Virus Infection
Interventions
DRUG

Nitroglycerin

2 mg/ml solution of nitroglycerin used for nebulization four hourly

Trial Locations (1)

54000

Bahria Town International Hospital, Lahore

All Listed Sponsors
lead

University of Lahore

OTHER

NCT04686760 - Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients | Biotech Hunter | Biotech Hunter